4//SEC Filing
Nussbaum Robert L 4
Accession 0000899243-21-044611
CIK 0001501134other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 5:07 PM ET
Size
13.2 KB
Accession
0000899243-21-044611
Insider Transaction Report
Form 4
Invitae CorpNVTA
Nussbaum Robert L
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2021-11-11$9.90/sh+13,269$131,363→ 259,319 total - Exercise/Conversion
Common Stock
2021-11-11$10.23/sh+16,406$167,833→ 275,725 total - Exercise/Conversion
Employee Stock Options (right to buy)
2021-11-11−16,406→ 53,594 totalExercise: $10.23Exp: 2026-03-31→ Common Stock (16,406 underlying) - Sale
Common Stock
2021-11-11$21.89/sh−29,675$649,568→ 246,050 total - Exercise/Conversion
Employee Stock Options (right to buy)
2021-11-11−13,269→ 40,080 totalExercise: $9.90Exp: 2025-08-04→ Common Stock (13,269 underlying)
Footnotes (5)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2021.
- [F2]Represents a weighted average sale price. Actual sale prices ranged from $21.62 to $22.30 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- [F3]Includes an aggregate of 84,134 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- [F4]The shares subject to this option are fully vested and exercisable.
- [F5]The shares subject to this option are fully vested and exercisable.
Documents
Issuer
Invitae Corp
CIK 0001501134
Entity typeother
Related Parties
1- filerCIK 0001640322
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 5:07 PM ET
- Size
- 13.2 KB